Skip to main content

Perigon Wealth Management, LLC

SEC CIK
0001575239
Latest filing
Aug 7, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Perigon Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
7,164
Value
$4.47M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Perigon Wealth Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,164$4.47M0.1%−516−6.7%ReducedHolders
Q1 20267,680$5.93M0.1%−156−2.0%ReducedHolders
Q4 20257,836$6.05M0.1%+1,135+16.9%AddedHolders
Q3 20256,701$3.77M0.1%+985+17.2%AddedHolders
Q2 20255,716$3.00M0.1%−1,432−20.0%ReducedHolders
Q1 20257,148$4.53M0.1%−17−0.2%ReducedHolders
Q4 20247,165$4.97M0.1%−1,396−16.3%ReducedHolders
Q3 20248,561$9.00M0.2%+242+2.9%AddedHolders
Q2 20248,319$8.74M0.3%+239+3.0%AddedHolders
Q1 20248,080$7.78M0.2%+1,968+32.2%AddedHolders
Q4 20236,112$5.37M0.2%+161+2.7%AddedHolders
Q3 20235,951$4.90M0.2%+560+10.4%AddedHolders
Q2 20235,391$3.87M0.2%+320+6.3%AddedHolders
Q1 20235,071$4.17M0.2%+240+5.0%AddedHolders
Q4 20224,831$3.49M0.2%+386+8.7%AddedHolders
Q3 20224,445$3.06M0.3%+1,205+37.2%AddedHolders
Q2 20223,240$1.92M0.2%+149+4.8%AddedHolders
Q1 20223,091$2.16M0.2%−430−12.2%ReducedHolders
Q4 20213,521$2.22M0.2%+13+0.4%AddedHolders
Q3 20213,508$2.12M0.2%+37+1.1%AddedHolders
Q2 20213,471$1.94M0.2%+15+0.4%AddedHolders
Q1 20213,456$1.64M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.